LarryPEbbertMD

PubMed

• 68 citations
  Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
  Ivana T. Croghan, Richard D. Hurt, Shaker R. Dakhil, Gary A. Croghan, Jeff A. Sloan, Paul J. Novotny, Kendrith M. Rowland, Albert M. Bernath, Mary L. Loots, Nguyet A. ...> ;Mayo Clinic Proceedings. 2007 Feb 1
• 97 citations
  The prevalence of weight concerns in a smoking abstinence clinical trial.
  Matthew M. Clark, Richard D. Hurt, Ivana T. Croghan, Christi A. Patten, Paul J. Novotny, Jeff A. Sloan, Shaker R. Dakhil, Gary A. Croghan, Edward J. Wos, Kendrith M. R...> ;Addictive Behaviors. 2006 Jul 1
• A phase II study of aerosolized GM-CSF in the treatment of metastatic melanoma to the lung.
  Markovic SN, Suman VJ, Dalton RJ, Allred JB, Nevala WK, Celis E, Alberts SR, Fitch TR, Egner JR, Ebbert LP> ;J. Clin. Oncol.. 2004-07-15
• 9 citations
  Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers
  Paul L. Schaefer, Randolph S. Marks, Michelle R. Mahoney, Jeff A. Sloan, Mitchell D. Bauman, Henry D. Tazelaar, John W. Kugler, James A. Mailliard, Larry P. Ebbert, Ma...> ;American Journal of Clinical Oncology. 2003 Jun 1
• 51 citations
  Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in...
  Gary A. Croghan, Jeff A. Sloan, Ivana T. Croghan, Paul J. Novotny, Richard D. Hurt, Wanda L. DeKrey, James A. Mailliard, Larry P. Ebbert, Debra K. Swan, Daniel J. Wals...> ;Nicotine & Tobacco Research. 2003 Jan 1
• 3 citations
  North Central Cancer Treatment Group Phase II study of 5-fluorouracil and high-dose levamisole for gastric and gastroesophageal cancer using survival as the primary en...
  Patrick A. Burch, Michael D. Keppen, Georgene Schroeder, Joseph Rubin, James E. Krook, Robert J. Dalton, James B. Gerstner, Miroslav T. Jancewicz, Larry P. Ebbert> ;American Journal of Clinical Oncology. 1999 Oct 1
• 66 citations
  Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy.
  Scott H. Okuno, Charles O. Woodhouse, Charles L. Loprinzi, Jeff A. Sloan, Beth I. LaVasseur, Danette Clemens-Schutjer, Debra K. Swan, Claudia Axvig, Larry P. Ebbert, M...> ;American Journal of Clinical Oncology. 1999 Jun 1
• 143 citations
  Granulocyte Colony-Stimulating Factor in Severe Chemotherapy-Induced Afebrile Neutropenia
  Lynn C. Hartmann, Loren K. Tschetter, Thomas M. Habermann, Larry P. Ebbert, Pauline Johnson, James A. Mailliard, Ralph Levitt, Vera J. Suman, Thomas E. Witzig, Harry S...> ;The New England Journal of Medicine. 1997 Jun 19
• 52 citations
  Phase II study of docetaxel in advanced soft tissue sarcomas.
  John H. Edmonson, Larry P. Ebbert, Antonio G. Nascimento, Sin-Ho Jung, Harry Mcgaw, James B. Gerstner> ;American Journal of Clinical Oncology. 1996 Dec 1
• 10 citations
  Phase II Trial of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced/Recurrent Endometrial Carcinoma
  Harry J. Long, Robert M. Langdon, Stephen S. Cha, Michael H. Veeder, Delano M. Pfeifle, James E. Krook, Larry P. Ebbert, Loren K. Tschetter, Steven G. Roshon> ;Gynecologic Oncology. 1995 Aug 1
• 28 citations
  Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.
  Harry J. Long, William G. Cross, Harry S. Wieand, Maurice J. Webb, James A. Mailliard, John W. Kugler, Loren K. Tschetter, Carl G. Kardinal, Larry P. Ebbert, Sandra Ra...> ;Gynecologic Oncology. 1995 May 1
• 12 citations
  A randomized phase II trial of amonafide or trimetrexate in patients with advanced non‐small cell lung cancer. A trial of the north central cancer treatment group
  Dean H. Gesme, James R. Jett, Dennis D. Schreffler, John Q. Su, James A. Mailliard, John F. Foley, James E. Krook, Andrew W. Maksymiuk, Alan K. Hatfield, Larry P. Ebbe...> ;Cancer. 1993 May 1
• 236 citations
  Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia
  Charles L. Loprinzi, Neil M. Ellison, Daniel J. Schaid, James E. Krook, Laurie M. Athmann, Ann Marie Dose, James A. Mailliard, Pauline Johnson, Larry P. Ebbert, L. H. ...> ;Journal of the National Cancer Institute. 1990 Jul 4
• 44 citations
  Cyclophosphamide-Cisplatin Versus Cyclophosphamide-Carboplatin in Stage III-IV Ovarian Carcinoma: A Comparison of Equally Myelosuppressive Regimens
  John H. Edmonson, G. M. Mccormack, Harry S. Wieand, John W. Kugler, James E. Krook, C. R. Stanhope, L. K. Everson, J. A. Laurie, Larry P. Ebbert, George D. Malkasian, ...> ;Journal of the National Cancer Institute. 1989 Oct 4
• 7 citations
  Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer
  Robert F. Marschke, James N. Ingle, Daniel J. Schaid, James E. Krook, James A. Mailliard, Stephen A. Cullinan, Delano M. Pfeifle, Henry J. Votava, Larry P. Ebbert, Har...> ;Cancer. 1989 May 15
• 394 citations
  Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response.
  Richard J. Dixon, Wendell F. Rosse, Larry Ebbert> ;The New England Journal of Medicine. 1975 Jan 30
• Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.
  Morton, R. F., Creagan, E. T., Cullinan, S. A., Mailliard, J. A., Ebbert, L., Veeder, M. H., Chang, M.> ;J Clin Oncol. 1987 Jul
• Join now to see all